Analysts’ average price target for Bioventus (BVS) implies 28.8% upside, supported by strong agreement as earnings estimates have been raised. The article notes price-target accuracy has historically been mixed, but the upward revision trend suggests modest near-term positive sentiment for the stock.
Analysts’ average price target for Bioventus (BVS) implies 28.8% upside, supported by strong agreement as earnings estimates have been raised. The article notes price-target accuracy has historically been mixed, but the upward revision trend suggests modest near-term positive sentiment for the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
